347 related articles for article (PubMed ID: 30633545)
1. GDF-15 in Pulmonary and Critical Care Medicine.
Verhamme FM; Freeman CM; Brusselle GG; Bracke KR; Curtis JL
Am J Respir Cell Mol Biol; 2019 Jun; 60(6):621-628. PubMed ID: 30633545
[TBL] [Abstract][Full Text] [Related]
2. Growth Differentiation Factor-15 Is a Predictor of Mortality in Critically Ill Patients with Sepsis.
Buendgens L; Yagmur E; Bruensing J; Herbers U; Baeck C; Trautwein C; Koch A; Tacke F
Dis Markers; 2017; 2017():5271203. PubMed ID: 29180833
[TBL] [Abstract][Full Text] [Related]
3. The Growth Differentiation Factor-15 (GDF-15) levels are increased in patients with compound heterozygous sickle cell and beta-thalassemia (HbS/β
Larissi K; Politou M; Margeli A; Poziopoulos C; Flevari P; Terpos E; Papassotiriou I; Voskaridou E
Blood Cells Mol Dis; 2019 Jul; 77():137-141. PubMed ID: 31071550
[TBL] [Abstract][Full Text] [Related]
4. Growth Differentiation Factor-15 Is a Novel Biomarker Predicting Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Mutlu LC; Altintas N; Aydin M; Tulubas F; Oran M; Kucukyalin V; Kaplan G; Gurel A
Inflammation; 2015 Oct; 38(5):1805-13. PubMed ID: 25820390
[TBL] [Abstract][Full Text] [Related]
5. Plasma Growth Differentiation Factor-15 is a Potential Biomarker for Pediatric Pulmonary Arterial Hypertension Associated with Congenital Heart Disease.
Li G; Li Y; Tan XQ; Jia P; Zhao J; Liu D; Wang T; Liu B
Pediatr Cardiol; 2017 Dec; 38(8):1620-1626. PubMed ID: 28819713
[TBL] [Abstract][Full Text] [Related]
6. GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease.
Martinez CH; Freeman CM; Nelson JD; Murray S; Wang X; Budoff MJ; Dransfield MT; Hokanson JE; Kazerooni EA; Kinney GL; Regan EA; Wells JM; Martinez FJ; Han MK; Curtis JL;
Respir Res; 2017 Feb; 18(1):42. PubMed ID: 28245821
[TBL] [Abstract][Full Text] [Related]
7. Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint.
Wischhusen J; Melero I; Fridman WH
Front Immunol; 2020; 11():951. PubMed ID: 32508832
[TBL] [Abstract][Full Text] [Related]
8. Growth differentiation factor-15 in children and adolescents with thalassemia intermedia: Relation to subclinical atherosclerosis and pulmonary vasculopathy.
Tantawy AA; Adly AA; Ismail EA; Youssef OI; Ali ME
Blood Cells Mol Dis; 2015 Aug; 55(2):144-50. PubMed ID: 26142330
[TBL] [Abstract][Full Text] [Related]
9. Acute exacerbations of chronic obstructive pulmonary disease are associated with decreased CD4+ & CD8+ T cells and increased growth & differentiation factor-15 (GDF-15) in peripheral blood.
Freeman CM; Martinez CH; Todt JC; Martinez FJ; Han MK; Thompson DL; McCloskey L; Curtis JL
Respir Res; 2015 Aug; 16(1):94. PubMed ID: 26243260
[TBL] [Abstract][Full Text] [Related]
10. Diabetes mellitus related biomarker: The predictive role of growth-differentiation factor-15.
Berezin AE
Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S154-7. PubMed ID: 26482961
[TBL] [Abstract][Full Text] [Related]
11. The relationship between insulin resistance and the cardiovascular biomarker growth differentiation factor-15 in obese patients.
Vila G; Riedl M; Anderwald C; Resl M; Handisurya A; Clodi M; Prager G; Ludvik B; Krebs M; Luger A
Clin Chem; 2011 Feb; 57(2):309-16. PubMed ID: 21164037
[TBL] [Abstract][Full Text] [Related]
12. Growth Differentiation Factor 15 as a Biomarker in Cardiovascular Disease.
Wollert KC; Kempf T; Wallentin L
Clin Chem; 2017 Jan; 63(1):140-151. PubMed ID: 28062617
[TBL] [Abstract][Full Text] [Related]
13. Growth Differentiation Factor-15 as a Predictor of Idiopathic Membranous Nephropathy Progression: A Retrospective Study.
Ham YR; Song CH; Bae HJ; Jeong JY; Yeo MK; Choi DE; Na KR; Lee KW
Dis Markers; 2018; 2018():1463940. PubMed ID: 29682097
[TBL] [Abstract][Full Text] [Related]
14. Growth differentiation factor 15 (GDF-15) in endocrinology.
Iglesias P; Silvestre RA; Díez JJ
Endocrine; 2023 Sep; 81(3):419-431. PubMed ID: 37129758
[TBL] [Abstract][Full Text] [Related]
15. Growth differentiation factor 15: A novel biomarker with high clinical potential.
Desmedt S; Desmedt V; De Vos L; Delanghe JR; Speeckaert R; Speeckaert MM
Crit Rev Clin Lab Sci; 2019 Aug; 56(5):333-350. PubMed ID: 31076013
[TBL] [Abstract][Full Text] [Related]
16. Growth-differentiation factor-15 in heart failure.
Kempf T; Wollert KC
Heart Fail Clin; 2009 Oct; 5(4):537-47. PubMed ID: 19631178
[TBL] [Abstract][Full Text] [Related]
17. GDF 15--A Novel Biomarker in the Offing for Heart Failure.
George M; Jena A; Srivatsan V; Muthukumar R; Dhandapani VE
Curr Cardiol Rev; 2016; 12(1):37-46. PubMed ID: 26750722
[TBL] [Abstract][Full Text] [Related]
18. GDF-15 Is Elevated in Children with Mitochondrial Diseases and Is Induced by Mitochondrial Dysfunction.
Montero R; Yubero D; Villarroya J; Henares D; Jou C; Rodríguez MA; Ramos F; Nascimento A; Ortez CI; Campistol J; Perez-Dueñas B; O'Callaghan M; Pineda M; Garcia-Cazorla A; Oferil JC; Montoya J; Ruiz-Pesini E; Emperador S; Meznaric M; Campderros L; Kalko SG; Villarroya F; Artuch R; Jimenez-Mallebrera C
PLoS One; 2016; 11(2):e0148709. PubMed ID: 26867126
[TBL] [Abstract][Full Text] [Related]
19. GDF-15, a future therapeutic target of glucolipid metabolic disorders and cardiovascular disease.
Xiao QA; He Q; Zeng J; Xia X
Biomed Pharmacother; 2022 Feb; 146():112582. PubMed ID: 34959119
[TBL] [Abstract][Full Text] [Related]
20. Association between growth differentiation factor 15 and left ventricular hypertrophy in hypertensive patients and healthy adults.
Kou H; Jin X; Gao D; Ma R; Dong X; Wei J; Wang X
Clin Exp Hypertens; 2018; 40(1):8-15. PubMed ID: 29035099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
